The latest price target for Nuvalent (NASDAQ:NUVL) was reported by HC Wainwright & Co. on December 30, 2024. The analyst firm set a price target for $110.00 expecting NUVL to rise to within 12 months (a possible 42.45% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Nuvalent (NASDAQ:NUVL) was provided by HC Wainwright & Co., and Nuvalent initiated their buy rating.

The last upgrade for Nuvalent Inc happened on April 1, 2024 when Leerink Partners raised their price target to $110. Leerink Partners previously had a market perform for Nuvalent Inc.

There is no last downgrade for Nuvalent.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nuvalent, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nuvalent was filed on December 30, 2024 so you should expect the next rating to be made available sometime around December 30, 2025.

While ratings are subjective and will change, the latest Nuvalent (NUVL) rating was a initiated with a price target of $0.00 to $110.00. The current price Nuvalent (NUVL) is trading at is $77.22, which is within the analyst’s predicted range.